Pharmaceutical company developing proprietary;abuse-deterrent products for the treatment of pain and in other indications
Egalet has raised €18M across 2 funding rounds from 3 investors, most recently a Growth/Late round in Sep 2013. Based in Denmark; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2013-09-01 | Growth/Late | €7.6M | Index Ventures | View deal → |
| 2012-05-01 | Series B | €11M | Atlas Venture,Index Ventures,Sunstone Capital | View deal → |
